Pathogenesis of rheumatoid arthritis

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is characterized by chronic, destructive synovial inflammation.
• The traditional view posits exogenous antigens triggering immune responses involving macrophages, T cells, and B cells.
• Human Leukocyte Antigen (HLA) molecules' role in antigen presentation supports the antigen-driven disease model.

Purpose of the Study:

• To explore the evolving understanding of RA pathogenesis, moving beyond simplified models.
• To investigate the role of molecular techniques, cytokines, adhesion molecules, and T cell behavior in RA.
• To examine the contribution of B cells, autoantibodies like rheumatoid factors (RFs), and genetic risk factors to RA.

Main Methods:

• Analysis of cellular components and molecular mediators within synovial lesions.
• Investigation of T cell repertoire, CD4 T cell clonal expansion, and tissue-infiltrating T cells.
• Genetic studies identifying risk factors, including HLA-DRB1 gene polymorphisms.

Main Results:

• T cell-depleting therapies showed limited efficacy, with T cells persisting and proliferating in joints.
• Rheumatoid factor (RF)-expressing B cells are part of normal immunity, with RF production influenced by HLA type.
• Genetic studies reveal that multiple nonpathologic risk determinants can cumulatively increase RA risk, with HLA-DRB1 being a significant factor.

Conclusions:

• RA pathogenesis is complex, likely involving multiple interacting genetic and non-immune factors, not just single triggers.
• Tissue-infiltrating T cells and genetic predispositions, particularly HLA variations, significantly influence RA disease patterns and severity.
• Future research should integrate genetic insights with complex pathogenetic mechanisms to advance understanding and treatment of RA.